Innovation is the Key to the Future of Medicine

Toby CosgroveCourtesy of The Cleveland ClinicBill Gates once said that if business in the 1980s was about quality and in the 1990s it was about reengineering, then in the 2000s it will be about velocity. The rate of change is brutal. Obsolescence doesn't creep anymore, it leaps. The situation is best expressed in the Latin phrase absolutum obsoletum: If it works, it's out of date. In terms of shelf life, any technology at the peak of its adoption curve has passed its expiration date. You need to

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Courtesy of The Cleveland Clinic

Bill Gates once said that if business in the 1980s was about quality and in the 1990s it was about reengineering, then in the 2000s it will be about velocity. The rate of change is brutal. Obsolescence doesn't creep anymore, it leaps. The situation is best expressed in the Latin phrase absolutum obsoletum: If it works, it's out of date. In terms of shelf life, any technology at the peak of its adoption curve has passed its expiration date. You need to foster innovation and continually relaunch proprietary technology, or prepare for diminishing returns.

What precisely does "innovation" mean in the context of health care? It's not just good ideas, as the world is full of ideas that go nowhere. An innovation is an idea that has been put to work. Having an idea doesn't make you an innovator any more than having a brush ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Toby Cosgrove

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours